Neurodegenerative Cerebellar Ataxia.
Rosenthal LS.
Continuum (Minneap Minn). 2022 Oct 1;28(5):1409-1434. doi: 10.1212/CON.0000000000001180.
The assessment and treatment of postural disorders in cerebellar ataxia: a systematic review.
Marquer A, Barbieri G, Pérennou D.
Ann Phys Rehabil Med. 2014 Mar;57(2):67-78. doi: 10.1016/j.rehab.2014.01.002. Epub 2014 Feb 6.
Evaluation of Cerebellar Ataxic Patients.
Radmard S, Zesiewicz TA, Kuo SH.
Neurol Clin. 2023 Feb;41(1):21-44. doi: 10.1016/j.ncl.2022.05.002. Epub 2022 Aug 31.
Ataxia.
Kuo SH.
Continuum (Minneap Minn). 2019 Aug;25(4):1036-1054. doi: 10.1212/CON.0000000000000753.
The inherited cerebellar ataxias: an update.
Coarelli G, Wirth T, Tranchant C, Koenig M, Durr A, Anheim M.
J Neurol. 2023 Jan;270(1):208-222. doi: 10.1007/s00415-022-11383-6. Epub 2022 Sep 24.
Lipid Dyshomeostasis and Inherited Cerebellar Ataxia.
Zhao J, Zhang H, Fan X, Yu X, Huai J.
Mol Neurobiol. 2022 Jun;59(6):3800-3828. doi: 10.1007/s12035-022-02826-2. Epub 2022 Apr 14.
Ion channel dysfunction in cerebellar ataxia.
Bushart DD, Shakkottai VG.
Neurosci Lett. 2019 Jan 1;688:41-48. doi: 10.1016/j.neulet.2018.02.005. Epub 2018 Feb 5.
[Sporadic Cerebellar Ataxia: Multiple System Atrophy and Mono System Atrophy].
Watanabe H, Ito M, Mizutani Y, Ueda A, Shima S.
Brain Nerve. 2020 Sep;72(9):931-937. doi: 10.11477/mf.1416201626.
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
Mitoma H, Manto M, Hampe CS.
Curr Neuropharmacol. 2019;17(1):33-58. doi: 10.2174/1570159X16666180917105033.
Treatment of cerebellar ataxia.
Jones TM, Shaw JD, Sullivan K, Zesiewicz TA.
Neurodegener Dis Manag. 2014;4(5):379-92. doi: 10.2217/nmt.14.27.
